معرفی
Katie Isabella Gallacher is a Senior Clinical Research Fellow at the School of Health and Wellbeing, University of Glasgow, specializing in treatment burden, multimorbidity, and stroke rehabilitation. Her work bridges clinical practice and health services research with a focus on patient-centered outcomes.
Her educational background includes:
- PhD (Grade A) from University of Glasgow (2010-2016)
- MBChB from University of Glasgow (1998-2004)
- BSc(MedSci) from University of Glasgow (2001-2002)
- DFSRH from Royal College of Obstetricians and Gynaecologists (2008-2009)
- MRCGP from Royal College of General Practitioners (2007-2008)
- FRCGP from Royal College of General Practitioners (2024-present)
Dr. Gallacher pioneered the development of PETS-Stroke, a patient-reported measure of treatment burden after stroke. Her research examines how multimorbidity, social inequalities, and healthcare systems impact treatment burden across chronic conditions. She employs mixed-methods approaches to understand patient experiences and optimize healthcare delivery, particularly focusing on minimizing treatment burden while maximizing patient capacity in stroke and other long-term conditions. Her conceptual model of treatment burden and patient capacity has influenced stroke care frameworks internationally.
Analysis of her 15 most recent publications reveals a dominant focus on treatment burden measurement across stroke (60%), heart failure (15%), cancer (7%), and kidney disease (10%). Her work increasingly integrates social determinants of health (25% of recent articles) and spans methodology development (35%), systematic reviews (30%), and implementation studies (20%). A significant trend is the expansion of burden of treatment theory into digital health contexts and military populations.
Her scientific recognition includes:
- Fellow of the Royal College of General Practitioners (FRCGP)
- Chief Scientist Office Clinical Academic Fellowship
- NES Clinical Academic Fellowship
As principal investigator, she has secured £1.2M in research funding from major organizations including Dunhill Medical Trust (£250k), Stroke Association (£420k), NHS Greater Glasgow and Clyde (£85k), Carnegie Trust (£75k), and Chief Scientist Office (£380k). Her projects address critical gaps in stroke rehabilitation, anticholinergic harm reduction in older adults, and treatment burden minimization. She actively mentors junior researchers through collaborative projects with Frances S. Mair's team and leads the MULTIPOINT study on multimorbidity and frailty.
Dr. Gallacher co-leads the Treatment Burden Research Group within the School of Health and Wellbeing, collaborating with clinical teams across NHS Greater Glasgow and Clyde. Her work integrates with the Scottish School of Primary Care and the Robertson Centre for Biostatistics, focusing on pragmatic implementation of research findings into Scottish healthcare policy.
